149. 片側痙攣・片麻痺・てんかん症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 34 / 薬物数 : 37 - (DrugBank : 16) / 標的遺伝子数 : 17 - 標的パスウェイ数 : 30
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
9060X
2010 Phase 4 EUCTR2009-015620-29-BE Belgium
Anatomical landmark-guided suprascapular nerve block
Abant Izzet Baysal University
2022 Phase 4 NCT05260125 Turkey
Baclofen
Mustafa Kemal University
2018 Phase 4 NCT03860662 Turkey
Berg balance scale
Uskudar State Hospital
2023 - NCT05871723 -
Botox
2010 Phase 4 EUCTR2009-015620-29-BE Belgium
Mustafa Kemal University
2018 Phase 4 NCT03860662 Turkey
Botulinum toxin
University of Ioannina
2020 Phase 1 NCT04630873 Greece
Botulinum toxin A
Nanjing Sports Institude
2014 - ChiCTR-ICR-15007022 China
Botulinum toxin type A
2010 Phase 4 EUCTR2009-015620-29-BE Belgium
Brivaracetam
UCB Japan Co., Ltd.
2019 Phase 3 JPRN-jRCT2080224076 Japan
2017 Phase 3 JPRN-jRCT2080223631 Asia except Japan;Japan
2017 Phase 3 JPRN-jRCT2080223559 Asia except Japan;Japan
BTX-A
Shanghai Yangzhi rehabilitation hospital
2024 Phase 1 ChiCTR2400093364 China
Capture
Zhongda Hospital of Southeast University
2024 - ChiCTR2400080158 China
Carbon
Hokkaido University of Science
2024 - JPRN-UMIN000053592 Japan
Conservative rehabilitation
Abant Izzet Baysal University
2021 - NCT05552742 Turkey
Edonerpic
FUJIFILM Toyama Chemical Co., Ltd
2019 Phase 2 JPRN-jRCT2080224564 Japan
Ezetimibe
Hengdian Wenrong Hospital
2025 Phase 1 ChiCTR2500099188 China
Fenfluramine
University Hospital Antwerp
2011 Phase 3 EUCTR2011-004114-42-BE Belgium
Gait analysis
University of Ioannina
2020 Phase 1 NCT04630873 Greece
HC-58
Asahi Kasei Pharma Corporation
2012 Phase 2 NCT01623622 Japan
Lacosamide
UCB Japan Co., Ltd.
2016 Phase 3 JPRN-jRCT2080223050 Asia except Japan;Europe;Japan;North America;Oceania
Levetiracetam
UCB Japan Co., Ltd.
2017 Phase 3 JPRN-jRCT2080223815 Japan
Measurement OF multifidus and gastrocnemius muscle thickness with ultrasound
Uskudar State Hospital
2023 - NCT05871723 -
Medicinal AIR
Assistance Publique - Hôpitaux de Paris
2008 Phase 3 NCT00632528 France
Melatonin
Hospices Civils de Lyon
2019 - NCT04020848 France
Meopa
Assistance Publique - Hôpitaux de Paris
2008 Phase 3 NCT00632528 France
Nociceptor flexor reflex
Mustafa Kemal University
2018 Phase 4 NCT03860662 Turkey
Onabotulinumtoxina FOR injection
Konya Beyhekim Training and Research Hospital
2022 Phase 4 NCT05615987 Turkey
Oxygen
Assistance Publique - Hôpitaux de Paris
2024 Phase 2 NCT06248645 France
The First Affiliated Hospital of Bengbu Medical College
2022 Phase 0 ChiCTR2200065699 China
Padsevonil
UCB Japan Co., Ltd.
2019 Phase 1 JPRN-jRCT2080224874 Japan
2019 Phase 3 JPRN-jRCT2080224661 Asia except Japan;Europe;Japan;North America;Oceania
2019 Phase 2-3 JPRN-jRCT2080224540 Europe;Japan;North America;Oceania
2018 Phase 2 JPRN-jRCT2080224509 Europe;Japan;North America
Sodium oxybate
University of Utah
2009 Phase 1/Phase 2 NCT00931164 United States
THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire
Hospices Civils de Lyon
2019 - NCT04020848 France
Time delay treatment OF botulinum toxin
University Hospital, Clermont-Ferrand
2005 Phase 3 NCT00276185 France
Tocilizumab
Peking University First Hospital
2024 Phase 4 ChiCTR2400085185 China
Triheptanoin
Institut National de la Santé Et de la Recherche Médicale, France
2015 Phase 2 NCT02408354 France
Ultrasound-guided suprascapular nerve block
Abant Izzet Baysal University
2022 Phase 4 NCT05260125 Turkey
Upper limb muscle block
Centre d'Investigation Clinique et Technologique 805
2015 - NCT02455232 France
Virtual balance training
Abant Izzet Baysal University
2021 - NCT05552742 Turkey
Whole exome sequencing
Institute of Child Health
2018 - NCT03857607 United Kingdom
2010 Phase 4 EUCTR2009-015620-29-BE Belgium
Anatomical landmark-guided suprascapular nerve block
Abant Izzet Baysal University
2022 Phase 4 NCT05260125 Turkey
Baclofen
Mustafa Kemal University
2018 Phase 4 NCT03860662 Turkey
Berg balance scale
Uskudar State Hospital
2023 - NCT05871723 -
Botox
2010 Phase 4 EUCTR2009-015620-29-BE Belgium
Mustafa Kemal University
2018 Phase 4 NCT03860662 Turkey
Botulinum toxin
University of Ioannina
2020 Phase 1 NCT04630873 Greece
Botulinum toxin A
Nanjing Sports Institude
2014 - ChiCTR-ICR-15007022 China
Botulinum toxin type A
2010 Phase 4 EUCTR2009-015620-29-BE Belgium
Brivaracetam
UCB Japan Co., Ltd.
2019 Phase 3 JPRN-jRCT2080224076 Japan
2017 Phase 3 JPRN-jRCT2080223631 Asia except Japan;Japan
2017 Phase 3 JPRN-jRCT2080223559 Asia except Japan;Japan
BTX-A
Shanghai Yangzhi rehabilitation hospital
2024 Phase 1 ChiCTR2400093364 China
Capture
Zhongda Hospital of Southeast University
2024 - ChiCTR2400080158 China
Carbon
Hokkaido University of Science
2024 - JPRN-UMIN000053592 Japan
Conservative rehabilitation
Abant Izzet Baysal University
2021 - NCT05552742 Turkey
Edonerpic
FUJIFILM Toyama Chemical Co., Ltd
2019 Phase 2 JPRN-jRCT2080224564 Japan
Ezetimibe
Hengdian Wenrong Hospital
2025 Phase 1 ChiCTR2500099188 China
Fenfluramine
University Hospital Antwerp
2011 Phase 3 EUCTR2011-004114-42-BE Belgium
Gait analysis
University of Ioannina
2020 Phase 1 NCT04630873 Greece
HC-58
Asahi Kasei Pharma Corporation
2012 Phase 2 NCT01623622 Japan
Lacosamide
UCB Japan Co., Ltd.
2016 Phase 3 JPRN-jRCT2080223050 Asia except Japan;Europe;Japan;North America;Oceania
Levetiracetam
UCB Japan Co., Ltd.
2017 Phase 3 JPRN-jRCT2080223815 Japan
Measurement OF multifidus and gastrocnemius muscle thickness with ultrasound
Uskudar State Hospital
2023 - NCT05871723 -
Medicinal AIR
Assistance Publique - Hôpitaux de Paris
2008 Phase 3 NCT00632528 France
Melatonin
Hospices Civils de Lyon
2019 - NCT04020848 France
Meopa
Assistance Publique - Hôpitaux de Paris
2008 Phase 3 NCT00632528 France
Nociceptor flexor reflex
Mustafa Kemal University
2018 Phase 4 NCT03860662 Turkey
Onabotulinumtoxina FOR injection
Konya Beyhekim Training and Research Hospital
2022 Phase 4 NCT05615987 Turkey
Oxygen
Assistance Publique - Hôpitaux de Paris
2024 Phase 2 NCT06248645 France
The First Affiliated Hospital of Bengbu Medical College
2022 Phase 0 ChiCTR2200065699 China
Padsevonil
UCB Japan Co., Ltd.
2019 Phase 1 JPRN-jRCT2080224874 Japan
2019 Phase 3 JPRN-jRCT2080224661 Asia except Japan;Europe;Japan;North America;Oceania
2019 Phase 2-3 JPRN-jRCT2080224540 Europe;Japan;North America;Oceania
2018 Phase 2 JPRN-jRCT2080224509 Europe;Japan;North America
Sodium oxybate
University of Utah
2009 Phase 1/Phase 2 NCT00931164 United States
THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire
Hospices Civils de Lyon
2019 - NCT04020848 France
Time delay treatment OF botulinum toxin
University Hospital, Clermont-Ferrand
2005 Phase 3 NCT00276185 France
Tocilizumab
Peking University First Hospital
2024 Phase 4 ChiCTR2400085185 China
Triheptanoin
Institut National de la Santé Et de la Recherche Médicale, France
2015 Phase 2 NCT02408354 France
Ultrasound-guided suprascapular nerve block
Abant Izzet Baysal University
2022 Phase 4 NCT05260125 Turkey
Upper limb muscle block
Centre d'Investigation Clinique et Technologique 805
2015 - NCT02455232 France
Virtual balance training
Abant Izzet Baysal University
2021 - NCT05552742 Turkey
Whole exome sequencing
Institute of Child Health
2018 - NCT03857607 United Kingdom